SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 97 filers reported holding SYNAGEVA BIOPHARMA CORP in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $37,937,000 | -5.6% | 388,980 | -10.2% | 0.10% | -5.9% |
| Q4 2014 | $40,182,000 | +28.0% | 433,042 | -5.1% | 0.10% | +29.1% |
| Q3 2014 | $31,401,000 | -69.9% | 456,547 | -54.1% | 0.08% | -33.6% |
| Q2 2014 | $104,344,000 | +255.6% | 995,650 | +181.5% | 0.12% | +77.6% |
| Q1 2014 | $29,345,000 | -10.5% | 353,685 | -30.2% | 0.07% | -8.2% |
| Q4 2013 | $32,789,000 | +21.1% | 506,623 | +18.5% | 0.07% | +17.7% |
| Q3 2013 | $27,071,000 | +266.3% | 427,594 | +143.0% | 0.06% | +264.7% |
| Q2 2013 | $7,391,000 | – | 175,978 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|